Clinical trials
Immunoblastic Lymphadenopathy trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| NCIC Clinical Trials Group | 2 |
| Arvinas Inc. | 1 |
| BeiGene | 1 |
| Children's Oncology Group | 1 |
| City of Hope Medical Center | 1 |
| Corvus Pharmaceuticals, Inc. | 1 |
| London Health Sciences Centre | 1 |
| Toronto Sunnybrook Regional Cancer Centre | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immunoblastic Lymphadenopathy | 12 |
| Lymphoma, Large-Cell, Anaplastic | 11 |
| Lymphoma, Large B-Cell, Diffuse | 7 |
| Burkitt Lymphoma | 6 |
| Lymphoma, Extranodal NK-T-Cell | 6 |
| Lymphoma, Non-Hodgkin | 6 |
| Lymphoma, T-Cell, Cutaneous | 6 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Lymphoma | 5 |
| Mycosis Fungoides | 5 |
Trials
Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.